You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BETi

Showing 1 - 15 of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Malignant Solid Tumor, Metastatic NUT Carcinoma, Unresectable Malignant Solid Tumor Trial (Abemaciclib, BET

Suspended
  • Metastatic Malignant Solid Neoplasm
  • +3 more
  • Boston, Massachusetts
    Dana-Farber - Harvard Cancer Center LAO
Sep 17, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in Boston, Galveston,

Suspended
  • Advanced Malignant Solid Neoplasm
  • +4 more
  • Boston, Massachusetts
  • +2 more
Oct 5, 2022

Advanced Malignant Solid Tumor, Advanced Ovarian Carcinoma, Metastatic Malignant Solid Tumor Trial (BET Bromodomain Inhibitor

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +7 more
  • Atlanta, Georgia
  • +2 more
Nov 3, 2022

Metastatic Colorectal Adenocarcinoma, Refractory Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8 Trial (drug,

Not yet recruiting
  • Metastatic Colorectal Adenocarcinoma
  • +2 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +6 more
  • (no location specified)
Oct 25, 2023

Hematopoietic and Lymphoid System Tumor, Metastatic Colorectal Carcinoma, Metastatic Malignant Solid Tumor Trial (BET

Not yet recruiting
  • Hematopoietic and Lymphoid System Neoplasm
  • +5 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +6 more
  • (no location specified)
Apr 6, 2023

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Triple-Negative Breast

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +4 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +3 more
  • (no location specified)
Jun 28, 2022

Advanced Lymphoma, Advanced Malignant Solid Tumor, Advanced Pancreatic Carcinoma Trial in New Haven (BET Bromodomain Inhibitor

Recruiting
  • Advanced Lymphoma
  • +13 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +2 more
  • New Haven, Connecticut
    Yale University Cancer Center LAO
Jun 29, 2022

Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor, Recurrent Platinum-Resistant Ovarian Carcinoma Trial in

Recruiting
  • Metastatic Malignant Solid Neoplasm
  • +3 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +2 more
  • Bethesda, Maryland
  • +4 more
Aug 16, 2022

Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma, Recurrent Endometrial Endometrioid

Not yet recruiting
  • Recurrent Endometrial Carcinoma
  • +8 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +7 more
  • (no location specified)
Jul 15, 2023

Metastatic Castration-Resistant Prostate Cancer Trial in China, United States (ZEN003694, Enzalutamide)

Recruiting
  • Metastatic Castration-Resistant Prostate Cancer
  • San Francisco, California
  • +21 more
Aug 18, 2022

Metastatic Castration-Resistant Prostate Cancer Trial in United States (ZEN003694, Enzalutamide)

Completed
Has Results
  • Metastatic Castration-Resistant Prostate Cancer
  • Los Angeles, California
  • +7 more
Nov 2, 2021

Cervical Cancer Trial in Seattle (DVD, Promotora)

Completed
  • Cervical Cancer
  • DVD
  • Promotora
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center
Nov 9, 2018

Metastatic Castration-Resistant Prostate Cancer Trial in United States (ZEN003694)

Completed
  • Metastatic Castration-Resistant Prostate Cancer
  • Los Angeles, California
  • +7 more
Nov 16, 2017

Diabetes, Pre-diabetes Trial (Home Health Party)

Completed
  • Diabetes
  • Pre-diabetes
  • Home Health Party
  • (no location specified)
Mar 4, 2015

Alzheimer Trial in Galdakao, Basauri, Bilbao (High intensity aerobic exercise+strength, Low intensity aerobic exercise+strength)

Unknown status
  • Alzheimer Disease
  • High intensity aerobic exercise+strength
  • Low intensity aerobic exercise+strength
  • Galdakao, Bilbao, Spain
  • +2 more
Jul 18, 2014